Collects samples from adults with cancer or pre-cancer to study why treatments work differently
Collects tissue and blood samples from adults with several cancers.
Key facts
- Who runs it
- National Cancer Institute (NCI)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 11 Apr 2016
- Expected to end
- 1 Dec 2032
- Type of study
- Observational
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years to 120 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who cannot take part
- Active concomitant medical or psychological illnesses that may increase the risk to the subject
- Inability to provide informed consent
- Pregnant or breastfeeding women
Other criteria
- INCLUSION CRITERIA:; Diagnosis of cancer, a premalignant/neoplastic condition or disease (such as an immunodeficiency) that increases the risk of being diagnosed with a cancer or premalignant/neoplastic condition; Age >=18 years of age; ECOG performance status of 0-3; Ability and willingness of subject to provide informed consent; Additional inclusion criteria pertinent only for participants undergoing apheresis
- Hemoglobin >= 8 mg/dL and platelet count > 75 K/microL
- Weight >= 48 kg
- Central line in place or adequate venous access
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Scott M Norberg, D.O.Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Cancer has a major impact in the United States and across the world. In 2015, over 1.5 million new cases of cancer were diagnosed in the U.S. Researchers want to study samples from people with cancer or a pre-malignant condition. They hope to develop more effective treatments.
Objective:
To better understand the biology of malignancies and why certain cancers respond differently to treatment.
Eligibility:
Adults at least 18 years old with cancer or a pre-cancerous condition.
Design:
Participants will be screened with a medical history, physical exam, and blood tests. Their diagnosis will be confirmed by the NCI Laboratory of Pathology.
Participants will send tissue blocks or slides from their original tumor biopsy.
At least once, participants will have a medical history, physical exam, and blood and urine tests.
Participants may have the following tests. They may have them more than once:
Apheresis. A needle in one arm removes blood. Blood is run through a machine and the sample cells are taken out. The rest of the blood is returned by a needle in the other arm.
Bone marrow aspiration and biopsy. The hipbone will be numbed. A needle will be put into the hipbone. Bone marrow will be taken out through the needle.
Piece of cancer tissue taken by a needle and syringe.
Computed tomography (CT) scan, magnetic resonance imaging (MRI) and/or positron emission tomography (PET) scan or ultrasound to help locate their tumor. For the scans, they lie in a machine that takes pictures.
A small piece of skin removed.
Participants will be contacted by phone once a year to find out how they are doing.
...
The group in the trial
- 1/Cohort 1
Patients with cancer or a premalignant condition or at risk of cancer from an immunodeficiency
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
- Plain-language title
- Collects samples from adults with cancer or pre-cancer to study why treatments work differentlyGenerated from the registry record. The registry title is the official one.
- Fit questions
- Built from NCT02682667, who can take part
- Record updated
- 12 November 2026